Canaccord Genuity Raises Twist Bioscience Price Target to $205
Canaccord Genuity raised its price target on Twist Bioscience to $205 per share from $120.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Canaccord Genuity raised its price target on Twist Bioscience to $205 per share from $120.